Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study (CTS).
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Belatacept (Primary) ; Calcineurin inhibitors
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms CTS
- Sponsors Bristol-Myers Squibb
- 18 Sep 2017 Status changed from active, no longer recruiting to completed.
- 07 Aug 2017 Planned End Date changed from 30 Apr 2018 to 30 Aug 2017.
- 07 Aug 2017 Planned primary completion date changed from 30 Apr 2018 to 30 Aug 2017.